LIPTIDE

WIPO WIPO 2018

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark LIPTIDE was filed as Word mark on 07/30/2018 at the World Intellectual Property Organization.

Trademark Details Last update: November 27, 2020

Trademark form Word mark
File reference 1428875
Countries China European Community Japan South Korea Mexico United States of America (USA)
Base trademark GB No. UK00003321897, July 2, 2018
Application date July 30, 2018
Expiration date July 30, 2028

Trademark owner

2nd Floor, 2 Woodberry Grove
London N12 0DR
GB

Trademark representatives

310 St. Vincent Street Glasgow G2 5RG GB

goods and services

05 Pharmaceutical preparations and substances; chemicals for pharmaceutical use; pharmaceuticals and pharmaceutical preparations being nanoparticles; pharmaceuticals and pharmaceutical preparations containing siRNA; pharmaceuticals and pharmaceutical preparations containing RNA; pharmaceuticals and pharmaceutical preparations containing shRNA; pharmaceuticals and pharmaceutical preparations containing mRNA; pharmaceuticals and pharmaceutical preparations containing DNA; drug delivery agents being made from lipids, liposomes or peptides; pharmaceuticals and pharmaceutical preparations containing lipids, liposomes or peptides; drug delivery agents; drug delivery agents that facilitate the delivery of pharmaceuticals and pharmaceutical preparations; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; pharmaceutical and drug delivery agents for use in relation to the delivery of siRNA, shRNA, mRNA, RNA, DNA or other genetic material; preparations for detecting genetic predispositions for medical purposes; pharmaceuticals and pharmaceutical preparations for use in gene therapy; drug delivery agents for use in gene therapy; drug delivery agents being nanoparticles; pharmaceutical and natural remedies; medical preparations; biochemical preparation for medical purposes; biological preparations for medical purposes; reagents for medical use; reagents for use in medical genetic testing; anti-cancer preparations; anti-cancer drugs; compounds for treating cancer; biopharmaceuticals for the treatment of cancer; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; anti-cancer preparations of microbial origin; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; anti-cancer preparations from hormones and antagonists; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment and prevention of tumours

Trademark history

Date Document number Area Entry
October 15, 2020 2020/42 Gaz JP Rejection
September 8, 2020 2020/37 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 15, 2020 2020/36 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 24, 2019 2019/43 Gaz JP Rejection
September 13, 2019 2020/6 Gaz MX Rejection
June 24, 2019 2019/26 Gaz KR Rejection
March 25, 2019 2019/13 Gaz EM Rejection
January 30, 2019 2019/6 Gaz CN Rejection
December 7, 2018 2018/50 Gaz US Rejection
July 30, 2018 2018/40 Gaz GB Registration

ID: 141428875